Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use

With high rates of unintended pregnancy in the United States, it is crucial for clinicians to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy. We review new contraceptive options including a nonhormonal intravaginal gel, hormonal contraceptives in the form of new pills, patches, and vaginal rings, and combined hormonal contraceptives that contain new estrogens as alternatives to ethinyl estradiol. We review updated prescribing methods for several established hormonal contraceptives such as depot medroxyprogesterone acetate, which is now available for subcutaneous self-injection. Additional choices of available contraceptive methods have important clinical implications that may remove unnecessary barriers to contraceptive use.

 

Comments：

It is indeed crucial for clinicians to be knowledgeable about the full range of contraceptive options available to their patients, as this knowledge can empower individuals to make informed decisions about their reproductive health and improve their reproductive autonomy. Advances in contraceptive technology have expanded the range of options available to patients, and it is important for clinicians to stay up-to-date on these developments.

Nonhormonal intravaginal gels, such as the contraceptive gel containing lactic acid, citric acid, and potassium bitartrate, offer a new option for individuals who may prefer nonhormonal contraception. Hormonal contraceptives in the form of new pills, patches, and vaginal rings, as well as combined hormonal contraceptives containing new estrogens, provide additional options for those who prefer hormonal contraception.

In addition to these new options, established hormonal contraceptives such as depot medroxyprogesterone acetate (DMPA) have also undergone updates to their prescribing methods. DMPA is now available for subcutaneous self-injection, which may remove barriers to access and improve patient convenience.

The availability of a wider range of contraceptive options has important clinical implications, as it allows clinicians to tailor their recommendations to the individual needs and preferences of their patients. This can help to remove unnecessary barriers to contraceptive use and improve overall reproductive health outcomes.It is indeed crucial for clinicians to be knowledgeable about the full range of contraceptive options available to their patients, as this knowledge can empower individuals to make informed decisions about their reproductive health and improve their reproductive autonomy. Advances in contraceptive technology have expanded the range of options available to patients, and it is important for clinicians to stay up-to-date on these developments.

Nonhormonal intravaginal gels, such as the contraceptive gel containing lactic acid, citric acid, and potassium bitartrate, offer a new option for individuals who may prefer nonhormonal contraception. Hormonal contraceptives in the form of new pills, patches, and vaginal rings, as well as combined hormonal contraceptives containing new estrogens, provide additional options for those who prefer hormonal contraception.

In addition to these new options, established hormonal contraceptives such as depot medroxyprogesterone acetate (DMPA) have also undergone updates to their prescribing methods. DMPA is now available for subcutaneous self-injection, which may remove barriers to access and improve patient convenience.

The availability of a wider range of contraceptive options has important clinical implications, as it allows clinicians to tailor their recommendations to the individual needs and preferences of their patients. This can help to remove unnecessary barriers to contraceptive use and improve overall reproductive health outcomes.

Related Products

Cat.No.	Product Name	Information
S2567	MPA (Medroxyprogesterone acetate)	MPA (Medroxyprogesterone acetate) is a synthetic progestin and act as a potent progesterone receptor agonist, used to treat abnormal menstruation or irregular vaginal bleeding.

Related Targets

Estrogen/progestogen Receptor